date:May 31, 2013
ther accept that their meat was produced with drugs, or agree to pay more for low-end meat marketed as all-natural.
The issue is whether you can get people to pay premium prices for non-premium cuts, said Michael Swanson, agricultural economist for Wells Fargo.
The debate over ractopamine use will also be closely watched by one of the pharmaceutical industry's largest players: Eli Lilly and Co., whose Elanco Animal Health unit is one of the leading producers of such medicated feed additives, a